IP Library › Granted Patent US 10,415,067
Granted Patent B2
US 10,415,067 · App. 15/313,416 · Granted Sep 17, 2019

Method for the enzymatic production of D-erythrose and acetyl phosphate

Inventor: Philippe Marliere (Tournai, BE)
Assignee: Scientist of Fortune, S.A.
C12P9/00C12N9/1025C12N9/88C12N9/92C12P7/24C12P7/26C12P19/02C12P19/40C12Y203/01008C12Y203/03015C12Y401/02004C12Y401/02009C12Y503/01005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,415,067
App. No.
15/313,416
Granted
Sep 17, 2019
Kind
B2
Abstract

Described is a method for the production of D-erythrose and acetyl phosphate comprising the enzymatic conversion of D-fructose into D-erythrose and acetyl phosphate by making use of a phosphoketolase. The produced D-erythrose can further be converted into glycolaldehyde by a method for the production of glycolaldehyde comprising the enzymatic conversion of D-erythrose into glycolaldehyde by making use of an aldolase, wherein aldolase is a 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4) or a fructose-bisphosphate aldolase (EC 4.1.2.13). The produced glycolaldehyde can finally be converted into acetyl phosphate by the enzymatic conversion of the thus produced glycolaldehyde into acetyl phosphate by making use of a phosphoketolase or a sulfoacetaldehyde acetyltransferase.

Claims (37)

1. A method of producing D-erythrose and acetyl phosphate comprising enzymatically converting D-fructose and phosphate into D-erythrose and acetyl phosphate by a phosphoketolase (EC 4.1.2.9) or a fructose-6-phosphate phosphoketolase (EC 4.1.2.22) wherein the phosphoketolase or fructose-6-phosphate phosphoketolase is obtained from fungi or bacteria.

2. The method of claim 1 , further comprising enzymatically converting D-erythrose into glycolaldehyde by an aldolase, wherein said aldolase is a 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4) or a fructose-bisphosphate aldolase (EC 4.1.2.13).

3. The method of claim 2 , wherein the method further comprises: enzymatically converting glycolaldehyde into acetyl phosphate by a phosphoketolase (EC 4.1.2.9), a fructose-6-phosphate phosphoketolase (EC 4.1.2.22), or a sulfoacetaldehyde acetyltransferase (EC 2.3.3.15).

4. The method of claim 1 , wherein the method further comprises enzymatically converting D-glucose into said D-fructose by a glucose-fructose isomerase.

5. The method of claim 4 , wherein said glucose-fructose isomerase is a xylose isomerase (EC 5.3.1.5).

6. The method of claim 1 , wherein said method is carried out in vitro.

7. The method of claim 2 , wherein said method is carried out in vitro).

8. The method of claim 1 , wherein the method is carried out in a microorganism expressing the phosphoketolase (EC 4.1.2.9) or the fructose-6-phosphate phosphoketolase (EC 4.1.2.22).

9. The method of claim 2 , wherein the method is carried out in a microorganism expressing the 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4) or the fructose-bisphosphate aldolase (EC 4.1.2.13).

10. The method of claim 1 , wherein the method further comprises enzymatically converting the acetyl phosphate into acetyl-CoA by a phosphotransacetylase in the presence of co-enzyme A (CoA).

11. The method of claim 2 , wherein the method further comprises enzymatically converting the acetyl phosphate into acetyl-CoA by a phosphotransacetylase in the presence of co-enzyme A (CoA).

12. The method of claim 3 , wherein the method further comprises enzymatically converting the acetyl phosphate into acetyl-CoA by a phosphotransacetylase in the presence of co-enzyme A (CoA).

13. The method of claim 6 , wherein the method further comprises enzymatically converting the acetyl phosphate into acetyl-CoA by a phosphotransacetylase in the presence of co-enzyme A (CoA).

14. The method of claim 4 , wherein the method further comprises enzymatically converting the acetyl phosphate into acetyl-CoA by a phosphotransacetylase in the presence of co-enzyme A (CoA).

15. The method of claim 5 , wherein the method further comprises enzymatically converting the acetyl phosphate into acetyl-CoA by a phosphotransacetylase in the presence of co-enzyme A (CoA).

16. The method of claim 7 , wherein the method further comprises enzymatically converting glycolaldehyde into acetyl phosphate by a phosphoketolase (EC 4.1.2.9) or the fructose-6-phosphate phosphoketolase (EC 4.1.2.22) or a sulfoacetaldehyde acetyltransferase (EC 2.3.3.15).

17. The method of claim 4 , wherein said method is carried out in vitro.

18. The method of claim 9 , wherein the method is carried out in a recombinant microorganism expressing:

(a) a recombinant phosphoketolase (EC 4.1.2.9) or the fructose-6-phosphate phosphoketolase (EC 4.1.2.22) and/or a recombinant sulfoacetaldehyde acetyltransferase (EC 2.3.3.15); and

(b) a recombinant 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4) or a recombinant fructose-bisphosphate aldolase (EC 4.1.2.13);

and optionally

(c) a recombinant glucose-fructose isomerase.

19. The method of claim 18 , wherein the recombinant microorganism expresses both the recombinant phosphoketolase (EC 4.1.2.9) or the fructose-6-phosphate phosphoketolase (EC 4.1.2.22) and the recombinant sulfoacetaldehyde acetyltransferase (EC 2.3.3.15).

20. The method of claim 4 , wherein said method is carried out in a microorganism expressing the recombinant glucose-fructose isomerase.

21. The method of claim 4 , wherein said glucose-fructose isomerase is a xylose isomerase (EC 5.3.1.5).

22. The method of claim 18 , wherein the recombinant microorganism is genetically modified to overexpress the recombinant phosphoketolase, the recombinant sulfoacetaldehyde acetyltransferase (EC 2.3.3.15), the recombinant 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4), the recombinant fructose-bisphosphate aldolase (EC 4.1.2.13) and/or the recombinant glucose-fructose isomerase, wherein the genetic modification is selected from:

(a) operably associating a heterologous promoter with a polynucleotide encoding the phosphoketolase, the sulfoacetaldehyde acetyltransferase (EC 2.3.3.15), the 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4), the fructose-bisphosphate aldolase (EC 4.1.2.13) and/or the glucose-fructose isomerase;

(b) transforming a heterologous polynucleotide encoding the phosphoketolase, the sulfoacetaldehyde acetyltransferase (EC 2.3.3.15), the 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4), the fructose-bisphosphate aldolase (EC 4.1.2.13) and/or the glucose-fructose isomerase into the recombinant microorganism; and/or

(c) introducing a mutation in the promoter of a polynucleotide encoding the phosphoketolase, the sulfoacetaldehyde acetyltransferase (EC 2.3.3.15), the 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4), the fructose-bisphosphate aldolase (EC 4.1.2.13), and/or the glucose-fructose isomerase wherein said mutation results in overexpression of the polynucleotide.

23. The method of claim 18 , wherein the recombinant microorganism is genetically modified to alter or improve the enzymatic activity of the recombinant phosphoketolase, the recombinant sulfoacetaldehyde acetyltransferase (EC 2.3.3.15), the recombinant 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4), the recombinant fructose-bisphosphate aldolase (EC 4.1.2.13) and/or the recombinant glucose-fructose isomerase, wherein the genetic modification is selected from:

(a) transforming a heterologous polynucleotide encoding the phosphoketolase, the sulfoacetaldehyde acetyltransferase (EC 2.3.3.15), the 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4), the fructose-bisphosphate aldolase (EC 4.1.2.13), and/or the glucose-fructose isomerase into the recombinant microorganism; and/or

(b) introducing a mutation into a polynucleotide encoding the phosphoketolase, the sulfoacetaldehyde acetyltransferase (EC 2.3.3.15), the 2-deoxyribose-5-phosphate aldolase (EC 4.1.2.4), the fructose-bisphosphate aldolase (EC 4.1.2.13), and/or the glucose-fructose isomerase wherein said mutation alters or improves enzymatic activity.

24. The method of claim 3 , wherein the phosphoketolase is different than the phosphoketolase used in converting D-fructose into D-erythrose and acetyl phosphate.

25. The method of claim 10 , wherein the method is carried out in vitro.

26. The method of claim 10 , wherein the method is carried out in a recombinant microorganism.

27. The method of claim 3 , wherein the method is carried out in vitro.

28. The method of claim 3 , wherein the method is carried out in a recombinant microorganism.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2016
From: MARLIERE, PHILIPPE
To: SCIENTIST OF FORTUNE, S.A.
Reel/Frame 040416/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2016
From: MARLIERE, PHILIPPE
To: SCIENTIST OF FORTUNE S.A.
Reel/Frame 040407/0885 →
Priority Claims (1)
EP 14169813 · May 26, 2014 · regional
Continuity (1)
Related Publication 20170191095A1 · Jul 6, 2017